Bendit I - Search Results

1

Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis.

Kantarjian HM, Hughes TP, Larson RA, Kim DW, Issaragrisil S, le Coutre P, Etienne G, Boquimpani C, Pasquini R, Clark RE, Dubruille V, Flinn IW, Kyrcz-Krzemien S, Medras E, Zanichelli M, Bendit I, Cacciatore S, Titorenko K, Aimone P, Saglio G, Hochhaus A. Kantarjian HM, et al. Among authors: bendit i. Leukemia. 2021 Feb;35(2):440-453. doi: 10.1038/s41375-020-01111-2. Epub 2021 Jan 7. Leukemia. 2021. PMID: 33414482 Free PMC article. Clinical Trial.

2

Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia.

Garicochea B, Giorgi R, Odone VF, Dorlhiac-Llacer PE, Bendit I. Garicochea B, et al. Among authors: bendit i. Leuk Res. 1998 Nov;22(11):1003-7. doi: 10.1016/s0145-2126(98)00076-9. Leuk Res. 1998. PMID: 9783802

3

Interferon-alpha therapy increases type I insulin-like growth factor receptors expression on lymphoid cells from patients with chronic myelogenous leukemia.

Oliveira MR, Ohnuma L, Bendit I, Dorlhiac-Lacer P, Giannella-Neto D. Oliveira MR, et al. Among authors: bendit i. Leuk Res. 2001 Aug;25(8):711-7. doi: 10.1016/s0145-2126(01)00011-x. Leuk Res. 2001. PMID: 11397478

4

Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study.

Conchon M, Sanabani SS, Bendit I, Santos FM, Serpa M, Dorliac-Llacer PE. Conchon M, et al. Among authors: bendit i. J Hematol Oncol. 2009 Oct 6;2:42. doi: 10.1186/1756-8722-2-42. J Hematol Oncol. 2009. PMID: 19807918 Free PMC article.

5

Current patient management of chronic myeloid leukemia in Latin America: a study by the Latin American Leukemia Net (LALNET).

Cortes J, De Souza C, Ayala-Sanchez M, Bendit I, Best-Aguilera C, Enrico A, Hamerschlak N, Pagnano K, Pasquini R, Meillon L. Cortes J, et al. Among authors: bendit i. Cancer. 2010 Nov 1;116(21):4991-5000. doi: 10.1002/cncr.25273. Cancer. 2010. PMID: 20665487 Free PMC article.

6

Dasatinib overrides imatinib resistance mediated by the F359I residue mutation in two patients with chronic myeloid leukemia.

Serpa M, Sanabani SS, Dorlhiac-Llacer PE, Nardinelli L, de Barros Ferreira P, Martins TF, Seguro F, Bendit I. Serpa M, et al. Among authors: bendit i. Acta Haematol. 2012;127(1):56-9. doi: 10.1159/000333092. Epub 2011 Nov 17. Acta Haematol. 2012. PMID: 22094354

7

Pretherapeutic expression of the hOCT1 gene predicts a complete molecular response to imatinib mesylate in chronic-phase chronic myeloid leukemia.

Nardinelli L, Sanabani SS, Didone A, Ferreira Pde B, Serpa M, Novaes MM, Marchiani M, Ruiz AL, Lima IS, Chamone Dde A, Bendit I. Nardinelli L, et al. Among authors: bendit i. Acta Haematol. 2012;127(4):228-34. doi: 10.1159/000336610. Epub 2012 Apr 13. Acta Haematol. 2012. PMID: 22508387

8

Evaluation of long-term outcomes, cytogenetic and molecular responses with imatinib mesylate in early and late chronic-phase chronic myeloid leukemia: a report from a single institute.

Bendit I, Sanabani SS, Conchon M, Serpa M, Novaes MM, Nardinelli L, Pereira TD, Tucunduva L, Ferreira Pde B, Dorlhiac-Llacer PE, Fischer Chamone Dde A. Bendit I, et al. Acta Haematol. 2012;128(4):223-32. doi: 10.1159/000339696. Epub 2012 Aug 22. Acta Haematol. 2012. PMID: 22922489 Clinical Trial.

9

Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale.

White HE, Hedges J, Bendit I, Branford S, Colomer D, Hochhaus A, Hughes T, Kamel-Reid S, Kim DW, Modur V, Müller MC, Pagnano KB, Pane F, Radich J, Cross NC, Labourier E. White HE, et al. Among authors: bendit i. Clin Chem. 2013 Jun;59(6):938-48. doi: 10.1373/clinchem.2012.196477. Epub 2013 Mar 7. Clin Chem. 2013. PMID: 23471097 Free article.

10

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

Experts in Chronic Myeloid Leukemia. Experts in Chronic Myeloid Leukemia. Blood. 2013 May 30;121(22):4439-42. doi: 10.1182/blood-2013-03-490003. Epub 2013 Apr 25. Blood. 2013. PMID: 23620577 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters